Cadrenal Advances Tecarfarin Manufacturing for Trial Readiness
May 15, 2025
Cadrenal Therapeutics, a biopharmaceutical company developing therapeutics for patients with cardiovascular disease, announced manufacturing and supply chain milestones for its lead drug candidate, tecarfarin, a